Trump administration authorizes CIA for covert action in Venezuela - Bloomberg
Investing.com - Truist Securities has reduced its price target on Carlisle (NYSE:CSL) to $350.00 from $380.00 while maintaining a Hold rating on the stock. The company, currently trading at $338.01, has seen its stock decline by approximately 22% over the past year, with analyst targets ranging from $370 to $444.
The adjustment follows negative market commentary and distribution ownership changes presented by Carlisle at a recent investor conference, which has raised questions about the company’s near-term performance. According to InvestingPro data, multiple analysts have recently revised their earnings expectations downward for the upcoming period.
Truist Securities noted that no quantification was provided regarding these concerns, creating uncertainty that will likely persist until Carlisle releases its full financial results.
The firm has lowered its 2025 EBITDA estimate for Carlisle to $1,242 million from the previous projection of $1,270 million.
Truist Securities believes investors will likely avoid Carlisle shares until the situation is clarified, with potential for additional downside pressure on the stock price.
In other recent news, Carlisle Companies Incorporated announced its second-quarter financial results for 2025, which did not meet analysts’ expectations. The company reported earnings per share of $6.27, which was below the anticipated $6.66. Additionally, revenue for the quarter came in at $1.4 billion, slightly missing the forecasted $1.49 billion. In a separate development, Carlisle has priced a public offering of $1 billion in notes. This offering includes $500 million in 5.250% notes due in 2035 and another $500 million in 5.550% notes due in 2040. The transaction is anticipated to close on August 20, 2025, pending standard closing conditions. These recent developments come amidst a backdrop of fluctuating market reactions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.